PIK3CA and cancer: Activating mutations in PIK3CA, which encodes the catalytic p110α subunit of class IA phosphoinositide 3-kinases (PI3Ks), contribute to cancer pathogenesis by promoting cell growth, survival, motility, and glucose metabolism.